Hoth Therapeutics, Inc.Hoth Therapeutics, Inc.Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪5.20 M‬USD
−2.44USD
‪−7.85 M‬USD
‪4.33 M‬
Beta (1Y)
1.83

About Hoth Therapeutics, Inc.

CEO
Robbie Knie
Headquarters
New York
Employees (FY)
6
Founded
2017
ISIN
US44148G2049
FIGI
BBG00H0HZ8S8
Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of HOTH is 1.19 USD — it has increased by 0.85% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Hoth Therapeutics, Inc. stocks are traded under the ticker HOTH.
Hoth Therapeutics, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
HOTH stock is 4.22% volatile and has beta coefficient of 1.83. Check out the list of the most volatile stocks — is Hoth Therapeutics, Inc. there?
One year price forecast for Hoth Therapeutics, Inc. has a max estimate of 7.00 USD and a min estimate of 4.00 USD.
HOTH earnings for the last quarter are −0.60 USD per share, whereas the estimation was −0.63 USD resulting in a 4.80% surprise. The estimated earnings for the next quarter are −0.51 USD per share. See more details about Hoth Therapeutics, Inc. earnings.
Yes, you can track Hoth Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
HOTH stock has fallen by 9.16% compared to the previous week, the month change is a 13.14% fall, over the last year Hoth Therapeutics, Inc. has showed a 41.38% decrease.
HOTH net income for the last quarter is ‪−1.70 M‬ USD, while the quarter before that showed ‪−2.09 M‬ USD of net income which accounts for 18.42% change. Track more Hoth Therapeutics, Inc. financial stats to get the full picture.
Today Hoth Therapeutics, Inc. has the market capitalization of ‪5.20 M‬, it has decreased by 2.19% over the last week.
No, HOTH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, HOTH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hoth Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
HOTH reached its all-time high on Feb 19, 2019 with the price of 347.00 USD, and its all-time low was 0.99 USD and was reached on Nov 15, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 6.00 employees. See our rating of the largest employees — is Hoth Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Hoth Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Hoth Therapeutics, Inc. stock shows the sell signal. See more of Hoth Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Hoth Therapeutics, Inc. future price: according to them, HOTH price has a max estimate of 7.00 USD and a min estimate of 4.00 USD. Read a more detailed Hoth Therapeutics, Inc. forecast: see what analysts think of Hoth Therapeutics, Inc. and suggest that you do with its stocks.